DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Cannabinol is an investigational drug.
There have been 38 clinical trials for Cannabinol. The most recent clinical trial was a Phase 2 trial, which was initiated on October 1st 2009.
The most common disease conditions in clinical trials are Marijuana Abuse, Chronic Pain, and Nausea. The leading clinical trial sponsors are Radboud University, Yale University, and Central Institute of Mental Health, Mannheim.
Recent Clinical Trials for Cannabinol
|Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products||Connecticut Pharmaceutical Solutions||Phase 1|
|Safety and Effects on Responses to Stress and Pain of Natural Medical Marijuana Products||Yale University||Phase 1|
|Cannabis For Cancer-Related Symptoms||Pippa Hawley||Phase 2|